高脂血症
多糖
疾病
医学
药理学
生物信息学
生物
糖尿病
生物化学
内科学
内分泌学
作者
Yongshuai Jing,Yunfeng Ma,Feibing Pan,Mingsong Li,Yuguang Zheng,Lanfang Wu,Danshen Zhang
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2022-03-15
卷期号:27 (6): 1903-1903
被引量:53
标识
DOI:10.3390/molecules27061903
摘要
Hyperlipidemia is a chronic metabolic disease caused by the abnormal metabolism of lipoproteins in the human body. Its main hazard is to accelerate systemic atherosclerosis, which causes cerebrovascular diseases such as coronary heart disease and thrombosis. At the same time, although the current hypolipidemic drugs have a certain therapeutic effect, they have side effects such as liver damage and digestive tract discomfort. Many kinds of polysaccharides from natural resources possess therapeutic effects on hyperlipidemia but still lack a comprehensive understanding. In this paper, the research progress of natural polysaccharides on reducing blood lipids in recent years is reviewed. The pharmacological mechanisms and targets of natural polysaccharides are mainly introduced. The relationship between structure and hypolipidemic activity is also discussed in detail. This review will help to understand the value of polysaccharides in lowering blood lipids and provide guidance for the development and clinical application of new hypolipidemic drugs.
科研通智能强力驱动
Strongly Powered by AbleSci AI